https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for South Africa.pdf
Buyer acknowledges that information in Seller’s
marketing materials, technical data sheets and other descriptive
publications distributed or published on its websites may vary from
time to time without notice.
Buyer acknowledges that Seller has furnished to Buyer
Safety Data Sheets, which include warnings together with safety and
health information concerning the Product and/or the containers for
such Product.
Data Protection.
https://www.avient.com/sites/default/files/resources/PolyOne_English-Thai_Terms_and_Conditions.pdf
Safety & Health Indemnity.
Buyer
acknowledges that Seller has furnished to
Buyer Material Safety Data sheets, which
include warnings together with safety and
health information concerning the Product
and/or the containers for such Product.
การรบัรองความปลอดภยั และสุขอนามยั ผูซื้7 อรบัทราบวา่
ผูข้ายไดส่้งมอบเอกสารขอ้มูลความปลอดภยั (Material Safety Data sheets)
ใหแ้ก่ผูซื้7 อแลว้ ซึ(งรวมถึงขอ้ควรระวงัต่างๆ
พรอ้มดว้ยขอ้มูลความปลอดภยัและสุขอนามยัเกี(ยวกบัสินคา้
และ/หรือบรรจุภณัฑข์องสินคา้ดงักล่าว ผูซ้ื7 อจะเผยแพรข่อ้มลูดงักลา่วเพื(อแจง้
ขอ้ควรระวงัเกี(ยวกบัอนัตรายต่างๆ ที(อาจเกดิขึ7 นแกบุ่คคลที(
ผูซื้7 อพึงคาดหมายไดต้ามสมควรวา่อาจไดร้บัอนัตรายดงักล่าว รวมถงึ
แต่ไม่จาํกดัเพียง ลกูจา้ง ตวัแทน ผูร้บัจา้ง
และลูกคา้ของผูซื้7 อ ผูซ้ื7 อจะชดใชค้วามเสียหาย แกต้่าง
และคุม้ครองผูข้ายใหป้ลอดพน้จากความรบัผิดทั7งปวงอนัเกิดจาก
หรือเกี(ยวเนื(องกบัการที(ผูซื้7 อมิไดเ้ผยแพร่ขอ้มลูดงักล่าว รวมถึง
แต่ไม่จาํกดัเพียง ความรบัผิดต่อการบาดเจ็บ การเจ็บป่วย การเสียชีวติ
และความเสียหายต่อทรพัยสิ์น และค่าใชจ่้ายในการตรวจสอบ
การฟ้องรอ้งดาํเนินคดี และค่าทนายความตามสมควร
11.
https://www.avient.com/knowledge-base/article/protecting-polymers-microbe-growth?ind[]=6596
Download PDF
https://www.avient.com/knowledge-base/article/protecting-polymers-microbe-growth?ind[]=6599
Download PDF
https://www.avient.com/knowledge-base/article/protecting-polymers-microbe-growth?ind[]=6601
Download PDF
https://www.avient.com/knowledge-base/article/three-ways-enhance-cosmetic-packaging-chemically-compatible-thermoplastic-elastomers-tpes
Download PDF
https://www.avient.com/sites/default/files/2021-01/mevopur-laser-welding-for-ivd-case-study-brief.pdf
GENOMIC DIAGNOSTIC
DEVICE MANUFACTURER
I N - V I T R O D I AG N O S T I C ( I V D ) D E V I C E
MEVOPURTM Laser-Transmitting and Laser-Absorbing
Pre-color Solution
AVIENT SOLUTION
• Customized solutions - Quality-by-Design (QdB) approach
• Optimized pigment / additive selection – good distribution in
final part minimizes welding failure
• Mitigated contamination and extractable risk on incoming raw
material with control based on fingerprinting
• Ensured uninterrupted supply from multiple ISO13485-2016
certified sites
• Minimized risk of change with change control agreements
WHY AVIENT
KEY REQUIREM ENTS
P R O D U C T I V I T Y & Q UA L I T Y
• Good weldability, low rejection rate
• Solutions in wide range of polymers, colors and
transparency
• Pre-tested ingredients to biocompatibility and
extractable metals
LEARN MORE
https://www.avient.com/products/polymer-additives/performance-enhancement-additives/mevopur-functional-additives
https://www.avient.com/products/polymer-colorants/healthcare-colorants
Mevopur™ Healthcare Bio-based Polymer Solutions
Mevopur™ Healthcare Functional Additives
Mevopur™ Bio-based Polymer Solutions
https://www.avient.com/products/polymer-additives/healthcare-additives
Mevopur™ Healthcare Functional Additives
Mevopur™ Healthcare Functional Additives
Mevopur™ Bio-based Polymer Solutions
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520BOAML%2520Basic%2520Materials%2520Conference%2520w%2520non-GAAP%252012%252011%25202014.pdf
Strong past performance demonstrates that our strategy and
execution are working
Megatrends and emerging opportunities align with our strengths
Innovation and services provide differentiation, incremental pricing
power, and competitive advantage
Strong and proven management team driving growth and
performance
Addressable market exceeds $40 billion
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
��PolyOne Investor Presentation�Bank of America Merrill Lynch �2014 US Basic Materials Conference�Boston, MA�December 11, 2014��
Forward-Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Confirmation of Our Strategy
Strategy and Execution Drive Results
Proof of Performance & 2015 Goals
32% Adjusted EPS CAGR from 2011
Innovation Drives Earnings Growth
A Rich Pipeline of Opportunity
Megatrends Aligned with Key End Markets
Debt Maturities & Pension Funding – 9/30/14
Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return
PolyOne Core Values
Why Invest In PolyOne?
Appendix
Q3 2014 Financial Highlights
At a Glance�Global Color, Additives and Inks
At a Glance�Global Specialty Engineered Materials
At a Glance�Designed Structures and Solutions
At a Glance�Performance Products and Solutions
At a Glance�Distribution
Plastics: Key to Future Sustainable Development
Commitment to Operational Excellence
Application Examples
Slide Number 28
Anti-Counterfeiting Solutions
2012 Range Rover Evoque Interior
Slide Number 31
Metal Replacement Solutions
Next Generation Solar Charger
High-Barrier Packaging Containers
Aerospace Applications
Non GAAP Rec - 11 5 14.pdf
Sidoti & Company non-GAAP Rec